
ãã¡ã€ã¶ãŒãšã¢ãã«ãã®ã³ããã¯ã¯ãã³ã«å¯ŸããFDAã®äžæ£ãªBLAæ¿èª | ãµãŒã·ã£ã»ã©ãã£ãã¯
æ³åããŠã¿ãŠãã ããïŒããæãç®èŠãããšé£éŠæ¿åºãäžæ°Žãå®å šé£²ææ°Žæ³ïŒSDWAïŒã«é©åãããšå®£èšãããšãããã¥ãŒã¹ãæµããŠããŸãã
FLASHLIGHTS PODCAST
JAN 29, 2026

ããã¯ãµãŒã·ã£ã»ã©ãã£ãã¯ãšã®é·ãã€ã³ã¿ãã¥ãŒã®æåã®éšåã§ãã
ç§ãã¡ã¯ã2025幎12æåæ¬ã«ãã«ãã¬ã³ãºã»ãã«ã¹ã»ãã£ãã§ã³ã¹ãæåºããããã¡ã€ã¶ãŒãšã¢ãã«ãã®æ°åã³ãããŠã€ã«ã¹ææçã¯ã¯ãã³ã®çç©åŠç補å€ã©ã€ã»ã³ã¹ç³è«æ¿èªïŒBLAïŒãåãæ¶ãããFDAã«æ±ããåžæ°è«é¡æžã«ã€ããŠè°è«ããŸãã
ã©ãã£ãã¯æ°ã¯è«é¡æžã®å€§éšåãå·çããŠãããã€ã³ã¿ãã¥ãŒã®ç¬¬ 2 éšã§ã¯è«é¡æžã«ã€ããŠè©³ãã説æããŸãã
顿š
ãããã®ææ¯ãª mRNA Covid ã·ã§ããã§ã¯ããã¹ãŠãããªãæ··ä¹±ããŸããåœåã圌ãã¯ç·æ¥äœ¿çšèš±å¯ãåããŠããŸãããããã®åŸFDAã¯åœŒãã«BLAã®æ¿èªãäžããŸããããBLAã®æ¿èªåŸ1幎以äžã»ãšãã©ã®ã¢ã¡ãªã«äººã«EUAã®äºé²æ¥çš®ãäžãç¶ããŸããããããŠãPREP æ³ã¯ããããã¹ãŠã«ãããŠã©ã®ãããªåœ¹å²ãæãããŠããã®ã§ããããïŒ
FDA ãè¡ã£ã BLA æ¿èªã²ãŒã ã®åºæ¬æŠå¿µãããã«çè§£ããã«ã¯ã次ã®ããšãæ³åããŠãã ãããããæãé£éŠæ¿åºãäžæ°Žãå®å šé£²ææ°Žæ³ïŒSDWAïŒã«æºæ ããŠãããšå®£èšãããšãããã¥ãŒã¹ã§ç®ãèŠããŸãããŸãEPAã¯ãäžæ°Žãå ¬å ±é£²ææ°Žäžã®æ±æç©è³ªã«é¢ããååºãå®ããå¥åº·ããŒã¹ã®åºæºã«æºæ ããŠããããšã確èªããã

èå£ããªã³ã«ããŸãããããŠãæ¡ã®å®ãããããäžæ°ŽãæµãåºãŸãã
äžæ°Žã¯PREPæ³ã®ä¿è·äžã§å»ç察çãšããŠå®£èšãããŠãããå šåœã®ãã¹ãŠã®èªæ²»äœãæ°Žéãªã©ã«è²¬ä»»ã®èªç±ãäžããããŠããããã飲ãããšã«æ±ºãããšããŠãç æ°ã«ãªã£ããšãã«æ¿åºã蚎ããããšã¯ã§ããªãã ããã
ãããããã®äŸãã¯ãããŸã§ããåœãŠã¯ãŸããŸãããçµå±ã®ãšãããæ¿åºãäžæ°Žãå®å šé£²ææ°Žæ³ã«æºæ ããŠãããšå®£èšããåã¯ãäžæ°Žãäœããã®ç·æ¥äœ¿çšèš±å¯ã®äžã«çœ®ããããä»äºãç¶ããããã«äžæ°Žã飲ãããšã矩åä»ãããããŠããŸããã§ããã
PS: ãã®é¡æšã¯ãEUA èªå¯çç©è£œå€ãš BLA èªå¯çç©è£œå€ã®éã®èŠå¶çµè·¯ã®éãã匷調ããããšã®ã¿ãç®çãšããŠããŸããããã ãã§ãããªããªããBLAã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã¯EUAã®ã¯ã¯ãã³æ¥çš®ãšåããããææ¯ã ããã§ãã圌ãã¯æåããç§ãã¡ã«äžæ°ŽãæäŸããŠãããŸããã
ç·æ¥äœ¿çšèš±å¯ããBLAæ¿èªãŸã§
2020幎12æãFDAã¯ãã¡ã€ã¶ãŒãšã¢ãã«ãã®äž¡æ¹ã®Covid-19âã¯ã¯ãã³âã®ç·æ¥äœ¿çšèš±å¯ãçºè¡ããŸãã
ç·æ¥äœ¿çšèš±å¯ã§ã¯ãå»è¬åãçç©è£œå€ãæ©åšãªã©ã®è£œå㯠FDA ã®å®å šèŠå¶ã«æºæ ããå¿ èŠã¯ãããŸããã
ããã8ãæåŸã®2021幎8æãFDAã¯ãã¡ã€ã¶ãŒã®Covidâ19ã¯ã¯ãã³ã®BLAæ¿èªãçºè¡ãããã®æ°ãæåŸã®2022幎1æã«ã¯ã¢ãã«ãã®ã¯ã¯ãã³ã®BLAæ¿èªãçºè¡ããŸããã
BLAæ¿èªãšã¯äœã§ããïŒ
BLAã¯Biologics License Applicationã®ç¥ã§ããããã¯ãçç©åŠç補å€ã¡ãŒã«ãŒãèšåºéçºåŸã« FDA ã«æåºããç³è«æžã§ãã
ç³è«ã FDA ã«ãã£ãŠæ¿èªãããããã«ã¯ã補åãé£éŠå»è¬åå±ã®å®å šèŠå¶ãåºæºã管çã«æºæ ããŠããå¿ èŠããããŸããFDA ã¯çç©åŠç BLA æ¿èªãäžããããšã§ããã®è£œåããã®ç¹å®ã®çšéã«å¯ŸããŠå®å šãçŽç²ã匷åã§ãããšå®£èšããŸãã
BLA ã©ã€ã»ã³ã¹çã®ã¯ã¯ãã³ã¯ãFDA ã®èŠåãšèŠå¶ã«å®å šã«æºæ ããŠãããšå®£èšãããŠãããããç·æ¥äœ¿çšèš±å¯ã®å¯Ÿè±¡ã§ã¯ãããŸããããããã£ãŠãç·æ¥äœ¿çšãèš±å¯ããçç±ã¯ãããŸããã§ããã
BLAãæ¿èªãããã¡ã€ã¶ãŒã®ã¯ã¯ãã³ã®ããŒãžã§ã³ã¯ã³ãã«ããã£ãšåŒã°ãããModerna ã®å ŽåãBLA ãæ¿èªããããŒãžã§ã³ã¯ Spikevax ãšåŒã°ããŸãã
Covid-19 ã·ã§ããã® EUA ããŒãžã§ã³ãš BLA ããŒãžã§ã³ã®éãã¯äœã§ããïŒ
補åã«é¢ããŠèšãã°ããããã¯åãã§ããåã mRNAãåãè質ããç²åããã¹ãŠåãã§ãã
補åã茞éã販売ã管çããè£œé æ¥è ããã³ãã®ä»ã®è ã«å¯Ÿãã責任ä¿è·ã«é¢ããŠãããããã¯åãã§ããã©ã¡ãã 2029 幎 12 æãŸã§ PREP ã®æ³åŸè²¬ä»»ã·ãŒã«ãã®å¯Ÿè±¡ãšãªããŸããè¬ç©ãããã€ã¹ããŸãã¯çç©åŠç補å€ã¯ãFDA ã«ãã£ãŠå®å šã«æ¿èªãŸãã¯èªå¯ãããå¯èœæ§ããããPREP æ³ã«åºã¥ãå»ç察çãšããŠåŒãç¶ãã«ããŒãããŸãã
ããããäžã§èª¬æããããã«ãèŠå¶äžã®å°äœãšããç¹ã§ã¯ãããã㯠2 ã€ã®ç°ãªãåç©ã§ãã1 ã€ã¯éåžžã® FDA èŠå¶ããå é€ããããã 1 ã€ã¯éµå®ããå¿ èŠããããŸãã
BLA ã®æ¿èªåŸãã¢ã¡ãªã«äººã¯ BLA ããŒãžã§ã³ã®ã·ã§ãããåãåããŸãããïŒ
ãããã圌ãã¯ããŸããã§ããã
圌ãã¯ã»ãšãã©ã®å ŽåãEUA ããŒãžã§ã³ãåãåãç¶ããŸããã
BLAã®æ¿èªãçºè¡ãããŠããçŽ18ãæåŸã®2023幎ã®åãé ãŸã§ããªãã¢ã¡ãªã«äººã«EUAçãæ³šå°ãããŠããã®ã§ããããïŒBLAãæ¿èªããã¯ã¯ãã³ãå©çšå¯èœã«ãªã£ãåŸãEUA補åãæ³šå°ããããšããåæ³ã ã£ãã®ã§ããããïŒ ç¢ºãã«ããã§ããã
BLA æ¿èªåŸã EUA ã¯ãã®ãŸãŸæ®ããŸãã
ãããŠããããåæ³ã ã£ãçç±ã¯ãmRNA ã·ã§ããã BLA ã®æ¿èªãåŸããšããå ã®ãã¡ã€ã¶ãŒ ã·ã§ãããšã¢ãã«ã ã·ã§ããã«å¯Ÿã㊠EUA ã®èªå¯ãç¶æãããŠããããã§ãã
å®éãã¯ã¯ãã³æ¥çš®ã«é¢ããEUAãåé€ãããã®ã¯ãããã5ãæåã®2025幎8æäžæ¬ã«ãªã£ãŠããã ã£ãã
ã€ãŸãããã¡ã€ã¶ãŒãšã¢ãã«ãã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³ã«å¯ŸããŠ2020幎12æã«çºè¡ãããEUAã¯ãã»ãŒ5å¹Žéæœè¡ãããŠããããšã«ãªãã
åã補åã FDA ã«å®å šã«æºæ ããããŒãžã§ã³ã§å ¥æå¯èœã«ãªã£ããšãã«ãFDA èŠåã«æºæ ããŠããªã補åãã EUA ãåãæ¶ãããªãã£ãã®ã¯è峿·±ãããšã§ã¯ãªãã§ããããïŒ
ããã¯æå³ããããŸããããïŒãããŠããã¯éåžžã«å±éºãªè¡çºã§ã¯ãªãã£ãã§ããããïŒäººã ãæ°ã¥ãããæè°ã¯èµ·ããªãã§ããããïŒ
ãããã2021 幎 8 æåœæããã¹ãŠãéåžžã«æ··ä¹±ããŠããããã人ã ã¯ãã¬ã€ãããŠããã²ãŒã ãããŸãçè§£ããŠããŸããã§ããããããäžæè°ã§ã¯ãããŸããã
å 害è ã®èŒªä»¥å€ã§ã¯ãäœãèµ·ãã£ãŠããã®ããŸã 誰ãããããã£ãŠããŸããã§ãããEUA 㯠EAU ãšæ··åãããŠããããã°ããã®éãç·æ¥äœ¿çšèš±å¯ã®éèŠæ§ã誰ãçè§£ããŠããŸããã§ãããæ¿åº/ã¡ãã£ã¢ã®ãããã¬ã³ããåœæ å ±ãåºç¯ãªæ€é²ã«ããã人ã ã¯æ··ä¹±ããæ¹åæèŠã倱ã£ãŠããŸããã
ã©ãã£ãã¯æ°ã¯ãBLAãæ¿èªããã¯ã¯ãã³ãå©çšå¯èœã«ãªã£ãåŸããªãEUAã®ã¯ã¯ãã³ãããã»ã©é·ãé䜿çšãããã®ãã¯å®å šã«ã¯æããã§ã¯ãªããšèªã£ãããã¡ã€ã¶ãŒã¯ãPREP æ³ã«ãã£ãŠä¿è·ãããŠããã«ãããããããæœåšçãªæ³çãŸãã¯è²¬ä»»ã®åé¡ã«ã€ããŠåå·çã§ãããïŒBLA ããŒãžã§ã³ã泚æããåã«ããã§ã«è³Œå ¥ããèšå€§ãªæ°ã® EUA ã·ã§ããã䜿ãåãããã§ãããïŒ
ãããšããEUA ããŒãžã§ã³ã®æ¹ãããã®äžŠå€ãã EUA ã¹ããŒã¿ã¹ã®ãããã§ããããã芳ç¹ããèŠãŠåªããŠããããã§ããããïŒ
FDAããã¡ã€ã¶ãŒãšã¢ãã«ãã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ãBLAã«äžæ£æ¿èª
ãã§ã«ææããããã«ãFDA ã®æ¿èªã·ãŒã«ãä»ããããŒãžã§ã³ã¯ EUA ããŒãžã§ã³ãšãŸã£ããåãã§ãããããæ¯æ§ã®ç¹ã§ã¯ã·ã§ããéã«éãã¯ãããŸããã
ããããç¹°ãè¿ãã«ãªããŸãããEUA 㯠FDA ã®èŠåãèŠå¶ããå é€ãããé調æ»çµè·¯ã§ãããããèŠå¶ãšæ³åŸã®é¢ã§éããçããŸãã
äžæ¹ãBLA èªå¯ã®çç©åŠç補å€ã¯æ²»é𿮵éã«ãããFDA ã®å®å šèŠåãèŠå¶ãæ £è¡ã«æºæ ããŠããå¿ èŠããããŸããå°ãªããšããããçè«ã§ãã
EUAã®æ°åã³ãããŠã€ã«ã¹ã¯ã¯ãã³æ¥çš®ã¯ãç·æ¥äœ¿çšèš±å¯ã«åºã¥ããŠå é€ãããŠãããããFDAã®èŠå¶ã«äžåºŠãåŸã£ãããšããªããåŸãããšããããšããªãã£ãã®ã¯æããã ã
ãããã£ãŠãFDA ããåæãããŠãã BLA ã®æ¿èªãåŸãããã«ããã¡ã€ã¶ãŒãšã¢ãã«ã㯠FDA ããæ¯ãåºãã«æ»ããæçµçã« BLA ã®æ¿èªã«ã€ãªããå¯èœæ§ã®ããæ²»éšçµè·¯ã«é¢ãã 1 幎ã«ãããæ ãéå§ããããæ±ãããããšæãããã§ããããæ¿èªã
ããããããã¯èµ·ãã£ãããšã§ã¯ãããŸãããFDAã¯ãã¡ã€ã¶ãŒãšã¢ãã«ãã«å¯Ÿãã詊éšãèšåºè©Šéšã補é ã³ã³ãã©ã€ã¢ã³ã¹åºæºãªã©ãåããããšãèŠæ±ããªãã£ãããã®ä»£ããã«ãFDA ã¯ããããã®è£œåãå®å šèŠå¶ã®ãããã«ãæºæ ããŠããªãããšãååã«æ¿ç¥ããäžã§ãBLA ã®æ¿èªã圌ãã«ææž¡ããã ãã§ãããäžæ°Žãæ°ŽãšããŠã
æ°å¹ŽåŸããµãŒã·ã£ã»ã©ãã£ãã¯ãã¡ã¢ãªãŒã»ãã©ã³ããã¢ãŒãã³ã»ã·ãªããã©ã€ã¢ã³ã»ããã«ãŒãªã©ã®äººã ã®ãããã§ãç§ãã¡ã¯ãã®ããšãç¥ã£ãŠããŸãã2021幎ãã2022幎åé ã«ãããèµ·ãã£ããšãããã®BLAã®æ¿èªã§äœãèµ·ãã£ãŠããã®ãã«ã€ããŠãå°éå®¶ã®éãå«ããŠå€§ããªæ··ä¹±ããããŸãããäžæ£è¡çºã®ççžãè§£æããã«ã¯ãFDAããã¡ã€ã¶ãŒãã¢ãã«ããªã©ããããŒã¿ãååŸããã®ã«äœå¹Žãããããå€ãã®èšŽèšãèµ·ããããã
CHDã®åžæ°è«é¡
CHDã®åžæ°è«é¡ã¯ãFDAã«æ°åã³ãããŠã€ã«ã¹ææçã¯ã¯ãã³ããäžæ£ãªBLAæ¿èªãåé€ããEUAèªå¯è£œåã®å°äœã«æ»ããã匷å¶ããããã®ç¬¬äžæ©ã«ãããªãã
ããããåŸ ã£ãŠãã ãããEUA ã¯ããååšããŸããïŒ2025幎8æã«åé€ãããŸããããããªããšãããã»ã©ã®å€§è殺ãåŒãèµ·ããããããã®ææ¯ã¯ã¯ãã³ã¯ãã€ãã«åžå Žããæé€ãããªããã°ãªããªãããšã«ãªããããã§ãããïŒ
HSSé·å®RFKã圌ããEUAã®äžã«æ»ãããšã決å®ããªãéããããã¯æ³åããã®ãé£ããã
ãã£ãã¿ãŒãº
0:00:05 CHDã«ãããã¡ã€ã¶ãŒãšã¢ãã«ãã®BLAæ€åãæ±ããåžæ°è«é¡
0:05:07 äžè¬ããã®åå¿ãšã³ã¡ã³ãæ°ã®èšé²
0:11:06 çç©åŠç補å€ãšã¯ïŒ FDAã®åºæ¬ã«ããŽãªãŒ
0:15:18Â åŸæ¥ã®çç©åŠç補å€ããmRNAãçç©åŠç補å€ããž
0:21:52 NDAãšBLAããããŠçç©åŠç補å€ã®ã«ãŒãã¢ãŠã
0:27:49 çç©åŠç補å€ãã¯ã¯ãã³ããããŠæ¥çã€ã³ã»ã³ãã£ã
0:31:19 çç©åŠç補å€ã®æé·ãšã¯ã¯ãã³ãžã®æ³šç®
0:31:41 EUAã®ã¿ã€ã ã©ã€ã³ãš2021幎ã®BLAæ¿èª
0:33:45 米åœã𿬧å·ã«ãããå ±åäœå±éãšã©ãã«å衚瀺ã®äž»åŒµ
0:36:15 EUAãšBLAã«é¢ããäžè¬åžæ°ãšå»åž«ã®æ··ä¹±
0:37:28 FOIAã®é å»¶ãšEUAãšEAUã®æ··ä¹±
0:39:40 FDAã®éåžžã®èŠåå€ã®å¯ŸçãšããŠã®EUA
0:43:42 EUAãšBLAã«ãããäžæ°Žãšé£²ææ°Žã®é¡äŒŒæ§
ãªãœãŒã¹
FDAã«COVIDã¯ã¯ãã³ã®ã©ã€ã»ã³ã¹ãåãæ¶ãããæç€ºãã
ãµãŒã·ã£ã»ã©ãã£ã㯠éå ±: Children's Health Defense ãç§ã®æèŠãšãšãã« FDA ã«æåºããåžæ°è«é¡æžã
çç©è£œå€ã©ã€ã»ã³ã¹ç³è«ïŒBLAïŒããã»ã¹ïŒCBERïŒ